Gene delivery to dendritic cells facilitated by a tumor necrosis factor alpha-competing peptide

Molecular Immunology

Volumn 41, Issue 8, 2004, Pages 741-749

  Chamarthy, Sai P ^a   Jia, Liang ^a   Kovacs, Jeffrey R ^a   Anderson, Karl R ^a   Shen, Hongmei ^b,c   Firestine, Steven M ^a   Meng, Wilson S ^a  

^a DUQUESNE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

cyclized and fluorescent labeled CYTYQGKLC; DCs; dendritic cells; naked DNA; nDNA; pTNF; pTNF K16; TNF ; TNF R1; TNF R2; tumor necrosis factor alpha; tumor necrosis factor receptor 1; tumor necrosis factor receptor 2

Indexed keywords

CYSTEINYLTYROSYLTHREONYLTYROSYLGLUTAMINYLGLYCYLLYSYLLEUCYLCYSTEINE; MICROSPHERE; PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; TYROSYLTHREONYLTYROSYLGLUTAMINYLGLYCYLLYSYLLEUCINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BONE MARROW; CELL LINE; CONTROLLED STUDY; DENDRITIC CELL; DNA BINDING; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN DOMAIN; STATISTICAL SIGNIFICANCE; TRANSGENE;

ANIMALS; DENDRITIC CELLS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMMUNE SYSTEM; MICE; MICROSPHERES; PEPTIDES; PLASMIDS; TRANSDUCTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 3242698679     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2004.04.022     Document Type: Article

References (51)

1. Arakawa T., Yphantis D.A. Molecular weight of recombinant human tumor necrosis factor-alpha. J. Biol. Chem. 262:1987;7484-7485
2. Arthur J.F., Butterfield L.H., Roth M.D., Bui L.A., Kiertscher S.M., Lau R., Dubinett S., Glaspy J., McBride W.H., Economou J.S. A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther. 4:1997;17-25
3. Baeyens K.J., De Bondt H.L., Raeymaekers A., Fiers W., De Ranter C.J. The structure of mouse tumour-necrosis factor at 1.4 A resolution: towards modulation of its selectivity and trimerization. Acta Crystallogr. D: Biol. Crystallogr. 55:1999;772-778
4. Banner D.W., D'Arcy A., Janes W., Gentz R., Schoenfeld H.J., Broger C., Loetscher H., Lesslauer W. Crystal structure of the soluble human 55 kDa TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell. 73:1993;431-445
5. Butz E.A., Bevan M.J. Differential presentation of the same MHC class I epitopes by fibroblasts and dendritic cells. J. Immunol. 160:1998;2139-2144
6. Carter P.H., Scherle P.A., Muckelbauer J.K., Voss M.E., Liu R.Q., Thompson L.A., Tebben A.J., Solomon K.A., Lo Y.C., Li Z., Strzemienski P., Yang G., Falahatpisheh N., Xu M., Wu Z., Farrow N.A., Ramnarayan K., Wang J., Rideout D., Yalamoori V., Domaille P., Underwood D.J., Trzaskos J.M., Friedman S.M., Newton R.C., Decicco C.P., Muckelbauer J.A. Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha. Proc. Natl. Acad. Sci. U.S.A. 98:2001;11879-11884
7. Cha S.S., Kim J.S., Cho H.S., Shin N.K., Jeong W., Shin H.C., Kim Y.J., Hahn J.H., Oh B.H. High resolution crystal structure of a human tumor necrosis factor-alpha mutant with low systemic toxicity. J. Biol. Chem. 273:1998;2153-2160
8. Chamarthy S.P., Kovacs J.R., McClelland E., Gattens D., Meng W.S. A cationic peptide consists of ornithine and histidine repeats augments gene transfer in dendritic cells. Mol. Immunol. 40:2003;483-490
9. Cho M.J., Juliano R. Macromolecular versus small-molecule therapeutics: drug discovery, development and clinical considerations. Trends Biotechnol. 14:1996;153-158
10. Cristiano R.J. Targeted, non-viral gene delivery for cancer gene therapy. Front Biosci. 3:1998;D1161-D1170
11. Diebold S.S., Kursa M., Wagner E., Cotten M., Zenke M. Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells. J. Biol. Chem. 274:1999a;19087-19094
12. Diebold S.S., Lehrmann H., Kursa M., Wagner E., Cotten M., Zenke M. Efficient gene delivery into human dendritic cells by adenovirus polyethylenimine and mannose polyethylenimine transfection. Hum. Gene Ther. 10:1999b;775-786
13. Eck M.J., Sprang S.R. The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding. J. Biol. Chem. 264:1989;17595-17605
14. Eck M.J., Ultsch M., Rinderknecht E., de Vos A.M., Sprang S.R. The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-A resolution. J. Biol. Chem. 267:1992;2119-2122
15. Erbacher P., Bettinger T., Belguise-Valladier P., Zou S., Coll J.L., Behr J.P., Remy J.S. Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J. Gene Med. 1:1999;210-222
16. Erikstein B.K., Smeland E.B., Blomhoff H.K., Funderud S., Prydz K., Lesslauer W., Espevik T. Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes. Eur. J. Immunol. 21:1991;1033-1037
17. Fu Z.Q., Harrison R.W., Reed C., Wu J., Xue Y.N., Chen M.J., Weber I.T. Model complexes of tumor necrosis factor-alpha with receptors R1 and R2. Protein Eng. 8:1995;1233-1241
18. Goppelt-Struebe M., Reiser C.O., Schneider N., Grell M. Modulation of tumor necrosis factor (TNF) receptor expression during monocytic differentiation by glucocorticoids. Inflamm. Res. 45:1996;503-507
19. Hackett N.R., Kaminsky S.M., Sondhi D., Crystal R.G. Antivector and antitransgene host responses in gene therapy. Curr. Opin. Mol. Ther. 2:2000;376-382
20. Haines A.M., Irvine A.S., Mountain A., Charlesworth J., Farrow N.A., Husain R.D., Hyde H., Ketteringham H., McDermott R.H., Mulcahy A.F., Mustoe T.L., Reid S.C., Rouquette M., Shaw J.C., Thatcher D.R., Welsh J.H., Williams D.E., Zauner W., Phillips R.O. CL22 - a novel cationic peptide for efficient transfection of mammalian cells. Gene Ther. 8:2001;99-110
21. Hasegawa A., Takasaki W., Greene M.I., Murali R. Modifying TNFalpha for therapeutic use: a perspective on the TNF receptor system. Mini Rev. Med. Chem. 1:2001;5-16
22. Hedley M.L. Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors. Expert Opin. Biol. Ther. 3:2003;903-910
23. Hohmann H.P., Remy R., Brockhaus M., van Loon A.P. Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J. Biol. Chem. 264:1989;14927-14934
24. Hohmann H.P., Remy R., Poschl B., van Loon A.P. Tumor necrosis factors-alpha and -beta bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-kappa B at low receptor occupancy and within minutes after receptor binding. J. Biol. Chem. 265:1990;15183-15188
25. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1992;1693-1702
26. Irvine A.S., Trinder P.K., Laughton D.L., Ketteringham H., McDermott R.H., Reid S.C., Haines A.M., Amir A., Husain R., Doshi R., Young L.S., Mountain A. Efficient nonviral transfection of dendritic cells and their use for in vivo immunization. Nat. Biotechnol. 18:2000;1273-1278
27. Jones E.Y., Stuart D.I., Walker N.P. Structure of tumour necrosis factor. Nature. 338:1989;225-228
28. Kollias G., Douni E., Kassiotis G., Kontoyiannis D. The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Ann. Rheum. Dis. 58:1999a;I32-I39
29. Kollias G., Douni E., Kassiotis G., Kontoyiannis D. On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol. Rev. 169:1999b;175-194
30. Kruszynski M., Shealy D.J., Leone A.O., Heavner G.A. Identification of TNF-alpha binding peptides from a D-amino acid hexapeptide library that specifically inhibit TNF-alpha binding to recombinant p55 receptor. Cytokine. 11:1999;37-44
31. Larregina A., Morelli A., Kolkowski E., Fainboim L. Flow cytometric analysis of cytokine receptors on human Langerhans' cells. Changes observed after short-term culture. Immunology. 87:1996;317-325
32. Larregina A.T., Morelli A.E., Kolkowski E., Sanjuan N., Barboza M.E., Fainboim L. Pattern of cytokine receptors expressed by human dendritic cells migrated from dermal explants. Immunology. 91:1997;303-313
33. Liu F., Huang L. Development of non-viral vectors for systemic gene delivery. J. Control Release. 78:2002;259-266
34. Liu, R.Y., Zuckerman, K.S., 1999. Peptide antagonists of tumor necrosis factor alpha. University of South Florida, United States.
35. Loetscher H., Stueber D., Banner D., Mackay F., Lesslauer W. Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors. J. Biol. Chem. 268:1993;26350-26357
36. Lotze M.T., Kost T.A. Viruses as gene delivery vectors: application to gene function, target validation, and assay development. Cancer Gene Ther. 9:2002;692-699
37. Meng W.S., Butterfield L.H., Ribas A., Dissette V.B., Heller J.B., Miranda G.A., Glaspy J.A., McBride W.H., Economou J.S. Alpha-fetoprotein- specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination. Cancer Res. 61:2001;8782-8786
38. Niidome T., Ohmori N., Ichinose A., Wada A., Mihara H., Hirayama T., Aoyagi H. Binding of cationic alpha-helical peptides to plasmid DNA and their gene transfer abilities into cells. J. Biol. Chem. 272:1997;15307-15312
39. Philip R., Brunette E., Ashton J., Alters S., Gadea J., Sorich M., Yau J., O'Donoghue G., Lebkowski J., Okarma T., Philip M. Transgene expression in dendritic cells to induce antigen-specific cytotoxic T cells in healthy donors. Cancer Gene Ther. 5:1998;236-246
40. Ribas A., Butterfield L.H., McBride W.H., Jilani S.M., Bui L.A., Vollmer C.M., Lau R., Dissette V.B., Hu B., Chen A.Y., Glaspy J.A., Economou J.S. Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells. Cancer Res. 57:1997;2865-2869
41. Santee S.M., Owen-Schaub L.B. Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization. J. Biol. Chem. 271:1996;21151-21159
42. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:1991;271-296
43. Steinman R.M., Dhodapkar M. Active immunization against cancer with dendritic cells: the near future. Int. J. Cancer. 94:2001;459-473
44. Stern M., Ulrich K., Geddes D.M., Alton E.W. Poly(D,L-lactide-co- glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo. Gene Ther. 10:2003;1282-1288
45. Tartaglia L.A., Weber R.F., Figari I.S., Reynolds C., Palladino M.A. Jr., Goeddel D.V. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. U.S.A. 88:1991;9292-9296
46. Thomson A.W. Designer dendritic cells for transplant tolerance. Transplant. Proc. 34:2002;2727-2728
47. Vandenabeele P., Declercq W., Vanhaesebroeck B., Grooten J., Fiers W. Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J. Immunol. 154:1995;2904-2913
48. Wagner E., Cotten M., Mechtler K., Kirlappos H., Birnstiel M.L. DNA-binding transferrin conjugates as functional gene-delivery agents: synthesis by linkage of polylysine or ethidium homodimer to the transferrin carbohydrate moiety. Bioconjug. Chem. 2:1991;226-231
49. Wolfert M.A., Dash P.R., Nazarova O., Oupicky D., Seymour L.W., Smart S., Strohalm J., Ulbrich K. Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA. Bioconjug. Chem. 10:1999;993-1004
50. Wu G.Y., Wu C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262:1987;4429-4432
51. Zhang X.M., Weber I., Chen M.J. Site-directed mutational analysis of human tumor necrosis factor-alpha receptor binding site and structure-functional relationship. J. Biol. Chem. 267:1992;24069-24075